HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:

BioTech Firm Envisions Personalized, Clock-Stopping Skin Care; Partner Wanted

This article was originally published in The Rose Sheet

  • News

Executive Summary

DermTech International, a company with patented technologies for the non-invasive collection of genetic material from skin as well as gene expression analyses, believes its work has major implications for anti-aging cosmeceuticals

You may also be interested in...



HelixLife Offers Customized Skin Care Based On Targeted DNA Analysis

HelixLife joins an elite pack fighting skin aging at the DNA level with a personalized skin-care solution designed to compensate for "disadvantaged genes.

HelixLife Offers Customized Skin Care Based On Targeted DNA Analysis

HelixLife joins an elite pack fighting skin aging at the DNA level with a personalized skin-care solution designed to compensate for "disadvantaged genes.

CellCeuticals To Debut On QVC, Touted As 300% Better Than Competition

CellCeuticals will introduce its namesake skin-care line on QVC in February, the first step in its drive to become a leader in biomedical skin care, a field it believes is redefining anti-aging
Table

View full table

Related Content

HBW Insight
Tags:
UsernamePublicRestriction

Register

RS016712

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By